Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 12, 2008. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share ownership changes and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by four individuals on May 9, 2008, at a price of £11.38 per share through the Company's Share Reward Plan. The individuals involved are Mr. J S Heslop, Mr. E J Gray, Mr. D Learmouth, and Mr. A P Witty. Each individual acquired 11 shares via the partnership element (personal contribution) and 11 shares via the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory notification compliant with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: May 9, 2008.
- Share Price: £11.38 per Ordinary share.
- Participants: Mr. J S Heslop, Mr. E J Gray, Mr. D Learmouth, and Mr. A P Witty.
- Acquisition Structure: 11 shares personal contribution and 11 shares company match per individual.
- Notification Date: May 12, 2008.